These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 9284834

  • 1. Molecular genetic analysis of giant cell glioblastomas.
    Meyer-Puttlitz B, Hayashi Y, Waha A, Rollbrocker B, Boström J, Wiestler OD, Louis DN, Reifenberger G, von Deimling A.
    Am J Pathol; 1997 Sep; 151(3):853-7. PubMed ID: 9284834
    [Abstract] [Full Text] [Related]

  • 2. Human glioblastomas with no alterations of the CDKN2A (p16INK4A, MTS1) and CDK4 genes have frequent mutations of the retinoblastoma gene.
    Ichimura K, Schmidt EE, Goike HM, Collins VP.
    Oncogene; 1996 Sep 05; 13(5):1065-72. PubMed ID: 8806696
    [Abstract] [Full Text] [Related]

  • 3. Genetic analyses for predictors of radiation response in glioblastoma.
    Shih HA, Betensky RA, Dorfman MV, Louis DN, Loeffler JS, Batchelor TT.
    Int J Radiat Oncol Biol Phys; 2005 Nov 01; 63(3):704-10. PubMed ID: 15978739
    [Abstract] [Full Text] [Related]

  • 4. Homozygous deletion of the MTS1/p16 and MTS2/p15 genes and amplification of the CDK4 gene in glioma.
    Sonoda Y, Yoshimoto T, Sekiya T.
    Oncogene; 1995 Nov 16; 11(10):2145-9. PubMed ID: 7478535
    [Abstract] [Full Text] [Related]

  • 5. Mutations of TP53, amplification of EGFR, MDM2 and CDK4, and deletions of CDKN2A in malignant astrocytomas.
    Biernat W, Debiec-Rychter M, Liberski PP.
    Pol J Pathol; 1998 Nov 16; 49(4):267-71. PubMed ID: 10323080
    [Abstract] [Full Text] [Related]

  • 6. CDKN2A gene deletions and loss of p16 expression occur in osteosarcomas that lack RB alterations.
    Nielsen GP, Burns KL, Rosenberg AE, Louis DN.
    Am J Pathol; 1998 Jul 16; 153(1):159-63. PubMed ID: 9665476
    [Abstract] [Full Text] [Related]

  • 7. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated.
    Ueki K, Ono Y, Henson JW, Efird JT, von Deimling A, Louis DN.
    Cancer Res; 1996 Jan 01; 56(1):150-3. PubMed ID: 8548755
    [Abstract] [Full Text] [Related]

  • 8. CDKN2A deletion in pediatric versus adult glioblastomas and predictive value of p16 immunohistochemistry.
    Purkait S, Jha P, Sharma MC, Suri V, Sharma M, Kale SS, Sarkar C.
    Neuropathology; 2013 Aug 01; 33(4):405-12. PubMed ID: 23311918
    [Abstract] [Full Text] [Related]

  • 9. Comparative molecular genetic profiles of anaplastic astrocytomas/glioblastomas multiforme and their subsequent recurrences.
    Saxena A, Shriml LM, Dean M, Ali IU.
    Oncogene; 1999 Feb 11; 18(6):1385-90. PubMed ID: 10022821
    [Abstract] [Full Text] [Related]

  • 10. CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation.
    Della Torre G, Pasini B, Frigerio S, Donghi R, Rovini D, Delia D, Peters G, Huot TJ, Bianchi-Scarra G, Lantieri F, Rodolfo M, Parmiani G, Pierotti MA.
    Br J Cancer; 2001 Sep 14; 85(6):836-44. PubMed ID: 11556834
    [Abstract] [Full Text] [Related]

  • 11. Molecular genetic correlates of p16, cdk4, and pRb immunohistochemistry in glioblastomas.
    Burns KL, Ueki K, Jhung SL, Koh J, Louis DN.
    J Neuropathol Exp Neurol; 1998 Feb 14; 57(2):122-30. PubMed ID: 9600204
    [Abstract] [Full Text] [Related]

  • 12. Cytogenetic and molecular genetic analyses of giant cell glioblastoma multiforme reveal distinct profiles in giant cell and non-giant cell subpopulations.
    Martinez R, Roggendorf W, Baretton G, Klein R, Toedt G, Lichter P, Schackert G, Joos S.
    Cancer Genet Cytogenet; 2007 May 14; 175(1):26-34. PubMed ID: 17498554
    [Abstract] [Full Text] [Related]

  • 13. High-resolution genomic copy number profiling of glioblastoma multiforme by single nucleotide polymorphism DNA microarray.
    Yin D, Ogawa S, Kawamata N, Tunici P, Finocchiaro G, Eoli M, Ruckert C, Huynh T, Liu G, Kato M, Sanada M, Jauch A, Dugas M, Black KL, Koeffler HP.
    Mol Cancer Res; 2009 May 14; 7(5):665-77. PubMed ID: 19435819
    [Abstract] [Full Text] [Related]

  • 14. Lack of germ-line mutations of CDK4, p16(INK4A), and p15(INK4B) in families with glioma.
    Gao L, Liu L, van Meyel D, Cairncross G, Forsyth P, Kimmel D, Jenkins RB, Lassam NJ, Hogg D.
    Clin Cancer Res; 1997 Jun 14; 3(6):977-81. PubMed ID: 9815774
    [Abstract] [Full Text] [Related]

  • 15. Malignant astrocytomas with homozygous CDKN2/p16 gene deletions have higher Ki-67 proliferation indices.
    Ono Y, Tamiya T, Ichikawa T, Kunishio K, Matsumoto K, Furuta T, Ohmoto T, Ueki K, Louis DN.
    J Neuropathol Exp Neurol; 1996 Oct 14; 55(10):1026-31. PubMed ID: 8857999
    [Abstract] [Full Text] [Related]

  • 16. Determination of p53 mutations, EGFR overexpression, and loss of p16 expression in pediatric glioblastomas.
    Sure U, Rüedi D, Tachibana O, Yonekawa Y, Ohgaki H, Kleihues P, Hegi ME.
    J Neuropathol Exp Neurol; 1997 Jul 14; 56(7):782-9. PubMed ID: 9210874
    [Abstract] [Full Text] [Related]

  • 17. Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors.
    Ueki K, Nishikawa R, Nakazato Y, Hirose T, Hirato J, Funada N, Fujimaki T, Hojo S, Kubo O, Ide T, Usui M, Ochiai C, Ito S, Takahashi H, Mukasa A, Asai A, Kirino T.
    Clin Cancer Res; 2002 Jan 14; 8(1):196-201. PubMed ID: 11801559
    [Abstract] [Full Text] [Related]

  • 18. Genetic profile of gliosarcomas.
    Reis RM, Könü-Lebleblicioglu D, Lopes JM, Kleihues P, Ohgaki H.
    Am J Pathol; 2000 Feb 14; 156(2):425-32. PubMed ID: 10666371
    [Abstract] [Full Text] [Related]

  • 19. Correlation among pathology, genotype, and patient outcomes in glioblastoma.
    Homma T, Fukushima T, Vaccarella S, Yonekawa Y, Di Patre PL, Franceschi S, Ohgaki H.
    J Neuropathol Exp Neurol; 2006 Sep 14; 65(9):846-54. PubMed ID: 16957578
    [Abstract] [Full Text] [Related]

  • 20. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.
    Boström J, Meyer-Puttlitz B, Wolter M, Blaschke B, Weber RG, Lichter P, Ichimura K, Collins VP, Reifenberger G.
    Am J Pathol; 2001 Aug 14; 159(2):661-9. PubMed ID: 11485924
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.